Skip Nav Destination
Long-term remission in multiply relapsed enteropathy-associated T-cell lymphoma following CD30 CAR T-cell therapy
Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients
A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN
Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects
Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya
Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial
A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma
Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trial
Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub
Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease
Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children’s Oncology Group
High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations
Issue Archive
December 8 2020
Table of Contents
EXCEPTIONAL CASE REPORTS
Long-term remission in multiply relapsed enteropathy-associated T-cell lymphoma following CD30 CAR T-cell therapy
Clinical Trials & Observations
Timothy J. Voorhees,Nilanjan Ghosh,Natalie Grover,Jared Block,Catherine Cheng,Kaitlin Morrison,Anastasia Ivanova,Gianpietro Dotti,Jonathan Serody,Barbara Savoldo,Anne W. Beaven
Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients
Clinical Trials & Observations
Susanne Ghandili,Susanne Pfefferle,Kevin Roedl,Piet Sonnemann,Panagiotis Karagiannis,Olaf Boenisch,Stefan Kluge,Stefan Schmiedel,Harald Ittrich,Holger Rohde,Marc Lütgehetmann,Katja Weisel,Carsten Bokemeyer,Dominic Wichmann,Walter Fiedler,Dominik Jarczak,Franziska Modemann
A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN
Clinical Trials & Observations
Wenbin Xiao,Linde A. Miles,Robert L. Bowman,Vidushi Durani,Helen S. Tian,Nicole L. DelGaudio,Tanmay Mishra,Menglei Zhu,Yanming Zhang,Sarah E. Stump,Martin S. Tallman,Ross L. Levine,Sheng F. Cai
REVIEW ARTICLE
Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects
Clinical Trials & Observations
CLINICAL TRIALS AND OBSERVATIONS
Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya
Clinical Trials & Observations
Sophie Uyoga,Alex W. Macharia,Carolyne M. Ndila,Gideon Nyutu,Mohammed Shebe,Kennedy O. Awuondo,Neema Mturi,Norbert Peshu,Benjamin Tsofa,J. Anthony G. Scott,Kathryn Maitland,Thomas N. Williams
Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial
Clinical Trials & Observations
Alden A. Moccia,Christian Taverna,Sämi Schär,Anna Vanazzi,Stéphanie Rondeau,Felicitas Hitz,Walter Mingrone,Thomas Pabst,Lidija Cevreska,Auro del Giglio,Johann Raats,Daniel Rauch,Daniel A. Vorobiof,Andreas Lohri,Céline Ruegsegger,Christine Biaggi Rudolf,Corinne Rusterholz,Stefanie Hayoz,Michele Ghielmini,Emanuele Zucca
A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma
Clinical Trials & Observations
Nikhil C. Munshi,Herve Avet-Loiseau,Kenneth C. Anderson,Paola Neri,Bruno Paiva,Mehmet Samur,Meletios Dimopoulos,Margarita Kulakova,Annette Lam,Mahmoud Hashim,Jianming He,Bart Heeg,Jon Ukropec,Jessica Vermeulen,Sarah Cote,Nizar Bahlis
Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trial
Clinical Trials & Observations
Meletios Dimopoulos,for the ASPEN investigators,Ramon Garcia Sanz,for the ASPEN investigators,Hui-Peng Lee,for the ASPEN investigators,Marek Trneny,for the ASPEN investigators,Marzia Varettoni,for the ASPEN investigators,Stephen Opat,for the ASPEN investigators,Shirley D'Sa,for the ASPEN investigators,Roger G. Owen,for the ASPEN investigators,Gavin Cull,for the ASPEN investigators,Stephen Mulligan,for the ASPEN investigators,Jaroslaw Czyz,for the ASPEN investigators,Jorge J. Castillo,for the ASPEN investigators,Marina Motta,for the ASPEN investigators,Tanya Siddiqi,for the ASPEN investigators,Mercedes Gironella Mesa,for the ASPEN investigators,Miquel Granell Gorrochategui,for the ASPEN investigators,Dipti Talaulikar,for the ASPEN investigators,Pier Luigi Zinzani,for the ASPEN investigators,Elham Askari,for the ASPEN investigators,Sebastian Grosicki,for the ASPEN investigators,Albert Oriol,for the ASPEN investigators,Simon Rule,for the ASPEN investigators,Janusz Kloczko,for the ASPEN investigators,Alessandra Tedeschi,for the ASPEN investigators,Christian Buske,for the ASPEN investigators,Veronique Leblond,for the ASPEN investigators,Judith Trotman,for the ASPEN investigators,Wai Y. Chan,for the ASPEN investigators,Jan Michel,for the ASPEN investigators,Jingjing Schneider,for the ASPEN investigators,Ziwen Tan,for the ASPEN investigators,Aileen Cohen,for the ASPEN investigators,Jane Huang,for the ASPEN investigators,Constantine S. Tam,for the ASPEN investigators
HEALTH SERVICES AND OUTCOMES
Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub
Clinical Trials & Observations
William A. Wood,Donna S. Neuberg,J. Colton Thompson,Martin S. Tallman,Mikkael A. Sekeres,Laurie H. Sehn,Kenneth C. Anderson,Aaron D. Goldberg,Nathan A. Pennell,Charlotte M. Niemeyer,Emily Tucker,Kathleen Hewitt,Robert M. Plovnick,Lisa K. Hicks
HEMATOPOIESIS AND STEM CELLS
LYMPHOID NEOPLASIA
Large-scale circular RNA deregulation in T-ALL: unlocking unique ectopic expression of molecular subtypes
Alessia Buratin,Maddalena Paganin,Enrico Gaffo,Anna Dal Molin,Juliette Roels,Giuseppe Germano,Maria Teresa Siddi,Valentina Serafin,Matthias De Decker,Stéphanie Gachet,Kaat Durinck,Frank Speleman,Tom Taghon,Geertruij te Kronnie,Pieter Van Vlierberghe,Stefania Bortoluzzi
Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma
Clinical Trials & Observations
Irena Misiewicz-Krzeminska,on behalf of the Grupo Español de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatías Malignas Cooperative Study Groups,Cristina de Ramón,on behalf of the Grupo Español de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatías Malignas Cooperative Study Groups,Luis A. Corchete,on behalf of the Grupo Español de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatías Malignas Cooperative Study Groups,Patryk Krzeminski,on behalf of the Grupo Español de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatías Malignas Cooperative Study Groups,Elizabeta A. Rojas,on behalf of the Grupo Español de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatías Malignas Cooperative Study Groups,Isabel Isidro,on behalf of the Grupo Español de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatías Malignas Cooperative Study Groups,Ramón García-Sanz,on behalf of the Grupo Español de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatías Malignas Cooperative Study Groups,Joaquín Martínez-López,on behalf of the Grupo Español de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatías Malignas Cooperative Study Groups,Albert Oriol,on behalf of the Grupo Español de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatías Malignas Cooperative Study Groups,Joan Bladé,on behalf of the Grupo Español de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatías Malignas Cooperative Study Groups,Juan-José Lahuerta,on behalf of the Grupo Español de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatías Malignas Cooperative Study Groups,Jesús San Miguel,on behalf of the Grupo Español de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatías Malignas Cooperative Study Groups,Laura Rosiñol,on behalf of the Grupo Español de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatías Malignas Cooperative Study Groups,María-Victoria Mateos,on behalf of the Grupo Español de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatías Malignas Cooperative Study Groups,Norma C. Gutiérrez,on behalf of the Grupo Español de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatías Malignas Cooperative Study Groups
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease
Clinical Trials & Observations
Frits van Rhee,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Eric Oksenhendler,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Gordan Srkalovic,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Peter Voorhees,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Megan Lim,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Angela Dispenzieri,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Makoto Ide,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Sophia Parente,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Stephen Schey,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Matthew Streetly,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Raymond Wong,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,David Wu,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Ivan Maillard,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Joshua Brandstadter,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Nikhil Munshi,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Wilbur Bowne,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Kojo S. Elenitoba-Johnson,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Alexander Fössa,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Mary Jo Lechowicz,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Shanmuganathan Chandrakasan,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Sheila K. Pierson,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Amy Greenway,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Sunita Nasta,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Kazuyuki Yoshizaki,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Razelle Kurzrock,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Thomas S. Uldrick,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Corey Casper,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,Amy Chadburn,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board,David C. Fajgenbaum,on behalf of the Castleman Disease Collaborative Network Scientific Advisory Board
MYELOID NEOPLASIA
Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children’s Oncology Group
Clinical Trials & Observations
Karen M. Chisholm,Amy E. Heerema-McKenney,John K. Choi,Jenny Smith,Rhonda E. Ries,Betsy A. Hirsch,Susana C. Raimondi,Todd A. Alonzo,Yi-Cheng Wang,Richard Aplenc,Lillian Sung,Alan S. Gamis,Soheil Meshinchi,Samir B. Kahwash
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous disease
Suk See De Ravin,Julie Brault,Ronald J. Meis,Linhong Li,Narda Theobald,Aylin C. Bonifacino,Hong Lei,Taylor Q. Liu,Sherry Koontz,Cristina Corsino,Marissa A. Zarakas,Jigar V. Desai,Aaron B. Clark,Uimook Choi,Mark E. Metzger,Kamille West,Steven L. Highfill,Elizabeth Kang,Douglas B. Kuhns,Michail S. Lionakis,David F. Stroncek,Cynthia E. Dunbar,John F. Tisdale,Robert E. Donahue,Gary A. Dahl,Harry L. Malech
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
Clinical Trials & Observations
Juliet N. Barker,Sean M. Devlin,Kristine A. Naputo,Kelcey Skinner,Molly A. Maloy,Lisa Flynn,Theodora Anagnostou,Scott T. Avecilla,Andromachi Scaradavou,Christina Cho,Parastoo B. Dahi,Sergio A. Giralt,Boglarka Gyurkocza,Alan M. Hanash,Katharine Hsu,Ann A. Jakubowski,Esperanza B. Papadopoulos,Jonathan U. Peled,Miguel-Angel Perales,Craig S. Sauter,Gunjan L. Shah,Brian C. Shaffer,Roni Tamari,James W. Young,Mikhail Roshal,Richard J. O’Reilly,Doris M. Ponce,Ioannis Politikos
VASCULAR BIOLOGY
Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations
Clinical Trials & Observations
Caroline Diorio,Kevin O. McNerney,Michele Lambert,Michele Paessler,Elizabeth M. Anderson,Sarah E. Henrickson,Julie Chase,Emily J. Liebling,Chakkapong Burudpakdee,Jessica H. Lee,Frances B. Balamuth,Allison M. Blatz,Kathleen Chiotos,Julie C. Fitzgerald,Therese M. Giglia,Kandace Gollomp,Audrey R. Odom John,Cristina Jasen,Tomas Leng,Whitney Petrosa,Laura A. Vella,Char Witmer,Kathleen E. Sullivan,Benjamin L. Laskin,Scott E. Hensley,Hamid Bassiri,Edward M. Behrens,David T. Teachey
-
Cover Image
Cover Image
COVER FIGURE
Transgenic lcr:EGFP zebrafish larva (72 hours postfertilization) injected with messenger RNA for epo and kitlga. See the article by Oltova et al. - PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Advertisement intended for health care professionals